Home/Filings/4/0001725160-24-000127
4//SEC Filing

Gallagher Cam 4

Accession 0001725160-24-000127

CIK 0001725160other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 6:27 PM ET

Size

328.0 KB

Accession

0001725160-24-000127

Insider Transaction Report

Form 4
Period: 2024-05-31
Transactions
  • Sale

    Common Stock

    2024-05-31$11.98/sh9,597$114,972633,680 total
Footnotes (1)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0001557832

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:27 PM ET
Size
328.0 KB